RBC Capital Maintains Outperform on CVS Health, Lowers Price Target to $108

Benzinga · 4d ago
RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $113 to $108.